ZURA: חוב לטווח קצר של החברה Zura Bio

This chart of Zura Bio Limited (ZURA) value on GURU.Markets, where the indicator stands at 0.00, is based on the successes of this innovator in autoimmune pathology therapy, which has earned scientific recognition. The business is protected by an antibody patent portfolio and high trial costs, which limit competition. Consequently, Zura Bio Limited (ZURA) creates innovative tools for strengthening immunity and combating severe diseases.

Short-term debt reflects the company's obligations with a maturity period of up to one year, measuring the business's reliance on external working capital financing. This metric allows an investor to assess liquidity risk and resilience to cash flow gaps. By analyzing short-term borrowing volumes, one can determine the efficiency of current liability management. For Zura Bio Limited (ZURA), a low debt load is critical during antibody development. Unique molecule licenses minimize pricing risks, stabilizing the financial profile.